Literature DB >> 19348972

Explaining pragmatic trials to pragmatic policymakers.

Malcolm Maclure1.   

Abstract

Mesh：

Year:  2009        PMID： 19348972     DOI： 10.1016/j.jclinepi.2008.06.021

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN： 0895-4356            Impact factor:   6.437


× No keyword cloud information.
  11 in total

1.  What kind of randomized trials do we need?

Authors:  Merrick Zwarenstein; Shaun Treweek
Journal:  CMAJ       Date:  2009-04-16       Impact factor: 8.262

2.  The Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) instrument was useful for refining a randomized trial design: experiences from an investigative team.

Authors:  Daniel L Riddle; Robert E Johnson; Mark P Jensen; Francis J Keefe; Kurt Kroenke; Matthew J Bair; Dennis C Ang
Journal:  J Clin Epidemiol       Date:  2010-06-17       Impact factor: 6.437

3.  Open-label randomized trial of titrated disease management for patients with hypertension: Study design and baseline sample characteristics.

Authors:  George L Jackson; Morris Weinberger; Miriam A Kirshner; Karen M Stechuchak; Stephanie D Melnyk; Hayden B Bosworth; Cynthia J Coffman; Brian Neelon; Courtney Van Houtven; Pamela W Gentry; Isis J Morris; Cynthia M Rose; Jennifer P Taylor; Carrie L May; Byungjoo Han; Christi Wainwright; Aviel Alkon; Lesa Powell; David Edelman
Journal:  Contemp Clin Trials       Date:  2016-07-12       Impact factor: 2.226

Review 4.  Data for cancer comparative effectiveness research: past, present, and future potential.

Authors:  Anne-Marie Meyer; William R Carpenter; Amy P Abernethy; Til Stürmer; Michael R Kosorok
Journal:  Cancer       Date:  2012-04-19       Impact factor: 6.860

Review 5.  A pragmatic view on pragmatic trials.

Authors:  Nikolaos A Patsopoulos
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

6.  Implementing Kanyini GAP, a pragmatic randomised controlled trial in Australia: findings from a qualitative study.

Authors:  Hueiming Liu; Luciana Massi; Anne-Marie Eades; Kirsten Howard; David Peiris; Julie Redfern; Tim Usherwood; Alan Cass; Anushka Patel; Stephen Jan; Tracey-Lea Laba
Journal:  Trials       Date:  2015-09-23       Impact factor: 2.279

7.  A pragmatic randomized trial comparing tablet computer informed consent to traditional paper-based methods for an osteoporosis study.

Authors:  A H Warriner; P J Foster; A Mudano; N C Wright; M E Melton; S E Sattui; W Calmbach; J R Curtis; M Kilgore; C E Lewis; W Pace; K G Saag
Journal:  Contemp Clin Trials Commun       Date:  2016-02-17

8.  Protocol for the process evaluation of interventions combining performance-based financing with health equity in Burkina Faso.

Authors:  Valéry Ridde; Anne-Marie Turcotte-Tremblay; Aurélia Souares; Julia Lohmann; David Zombré; Jean Louis Koulidiati; Maurice Yaogo; Hervé Hien; Matthew Hunt; Sylvie Zongo; Manuela De Allegri
Journal:  Implement Sci       Date:  2014-10-12       Impact factor: 7.327

9.  When are clinical trials beneficial for study patients and future patients? A factorial vignette-based survey of institutional review board members.

Authors:  Rahul Mhaskar; Branko Miladinovic; Thomas M Guterbock; Benjamin Djulbegovic
Journal:  BMJ Open       Date:  2016-09-28       Impact factor: 2.692

10.  The impact of pragmatic vs. prescriptive study designs on the outcomes of low back and neck pain when using mobilization or manipulation techniques: a systematic review and meta-analysis.

Authors:  Daniel Roenz; Jake Broccolo; Steven Brust; Jordan Billings; Alexander Perrott; Jeremy Hagadorn; Chad Cook; Joshua Cleland
Journal:  J Man Manip Ther       Date:  2017-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.